Adult Acute Lymphoblastic Leukemia Treatment (PDQ®)

Taking Hope from Molecularly Targeted Therapy

FDA Rounded out 2018 With Three Oncology Approvals

AACR’s Latest Journal, Blood Cancer Discovery, Publishes First Paper